GGrantIndex
← Leaderboards

Svend O Freytag

Henry Ford Health System

$5,645,392
Attributed
$5,645,392
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.2M · FY200516
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$12,804,218 · 7

By mechanism

P01$9,693,210 · 3
R01$2,803,414 · 3
R21$307,594 · 1

Top collaborators

No co-investigators on record.

Most similar at Henry Ford Health System

Same institution · by research overlap

Others in their field

Top investigators on “Gene Therapy

Research focus

Gene TherapyProdrugsGene ExpressionInjection Of Therapeutic AgentGanciclovirAdenovirusesCellsP53 Gene /ProteinLaboratory MouseSuicide GeneMalignant Neoplasm Of ProstateAdenoviridaePreclinical StudyRadiationSuicide Gene TherapyImmuneClinicGenerationsIn VivoCancer TherapyClinical TrialsBaseProgramsToxic Effect

Grant awards (29)

Gene Therapy and Radiation Therapy for Prostate Cancer$273,589
R01 · FY2016 · CA · contact PI
Gene Therapy and Radiation Therapy for Prostate Cancer$303,988
R01 · FY2015 · CA · contact PI
Gene Therapy and Radiation Therapy for Prostate Cancer$294,868
R01 · FY2014 · CA · contact PI
Gene Therapy and Radiation Therapy for Prostate Cancer$285,749
R01 · FY2013 · CA · contact PI
Gene Therapy and Radiation Therapy for Prostate Cancer$303,988
R01 · FY2012 · CA · contact PI
Molecular Gene and Radiation Therapies for Cancer$18,702
P01 · FY2009 · CA · contact PI
Molecular Gene and Radiation Therapies for Cancer$1,350,392
P01 · FY2008 · CA · contact PI
Second Generation Adenoviral Vectors for Cancer Therapy$302,888
P01 · FY2008 · CA · contact PI
CORE--Molecular Biology and Vector Core$164,294
P01 · FY2008 · CA · contact PI
Molecular Gene and Radiation Therapies for Cancer$1,347,203
P01 · FY2007 · CA · contact PI
Second Generation Adenoviral Vectors for Cancer Therapy$300,250
P01 · FY2007 · CA · contact PI
CORE--Molecular Biology and Vector Core$162,867
P01 · FY2007 · CA · contact PI
Molecular Gene and Radiation Therapies for Cancer$1,355,190
P01 · FY2006 · CA · contact PI
Second Generation Adenoviral Vectors for Cancer Therapy$284,882
P01 · FY2006 · CA · contact PI
CORE--Molecular Biology and Vector Core$154,528
P01 · FY2006 · CA · contact PI
Molecular Gene and Radiation Therapies for Cancer$1,585,764
P01 · FY2005 · CA
CORE--Molecular Biology and Vector Core$314,359
P01 · FY2005 · CA
Second Generation Adenoviral Vectors for Cancer Therapy$276,584
P01 · FY2005 · CA
Molecular Gene and Radiation Therapies for Cancer$1,501,575
P01 · FY2004 · CA
CORE--Molecular Biology and Vector Core$305,202
P01 · FY2004 · CA
Second Generation Adenoviral Vectors for Cancer Therapy$268,530
P01 · FY2004 · CA
Combined Suicide Gene Therapy/Radiotherapy for Cancer$261,595
R01 · FY2003 · CA
TRIMODAL GENE THERAPY FOR PROSTATE CANCER$145,339
R01 · FY2003 · DK
Combined Suicide Gene Therapy/Radiotherapy for Cancer$261,595
R01 · FY2002 · CA
TRIMODAL GENE THERAPY FOR PROSTATE CANCER$141,106
R01 · FY2002 · DK
Combined Suicide Gene Therapy/Radiotherapy for Cancer$261,595
R01 · FY2001 · CA
TRIMODAL GENE THERAPY FOR PROSTATE CANCER$136,996
R01 · FY2001 · DK
PHASE I STUDY OF COMBINED VIRAL &SUICIDE GENE THERAPIES$307,594
R21 · FY2000 · CA
TRIMODAL GENE THERAPY FOR PROSTATE CANCER$133,006
R01 · FY2000 · DK